ArticleJournal of cancer survivorship : research and practice2026
Perceptions of terminology among individuals known to oncology services: a cross sectional survey.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWhile the term "cancer survivor" is commonly used, existing definitions vary, and people with cancer may relate to the term differently. This study aimed to assess how people diagnosed with cancer perceive the label "cancer survivor" and to explore their preferences for alternative terminology.
methodsThis was a single-centre cross-sectional study. Oncology patients completed a questionnaire assessing their preferences for healthcare terminology, and the term "cancer survivor."
resultsA total of 387 participants completed the survey; most were female (93.0%) and had breast cancer (89.1%). Over half (58.1%) moderately or strongly liked the term "cancer survivor," and 61.7% moderately or strongly agreed with the National Cancer Institute definition. Participants most commonly identified individuals who had completed anticancer treatment with no known cancer present as a "cancer survivor," whereas only 12.9% felt the term applied to those with progressive or terminal disease. "Patient" was the most preferred descriptor (62.5% moderately or strongly liked), followed by "oncology patient," compared with more consumer-oriented terms such as "client," which 22.2% moderately or Most participants (68.8%) considered terminology to be important or very important. Qualitative responses revealed that some viewed "cancer survivor" as empowering and encouraging, while others felt it did not accurately reflect their experience and evoked fear or discomfort.
conclusionThese findings highlight some variability in how oncology patients relate to the term "cancer survivor" and emphasize the need for more inclusive, person-centered language. IMPLICATIONS FOR CANCER SURVIVORS: Healthcare professionals should consider using patient-informed terminology that respects their experiences across the cancer continuum.
Indexed as
Identifiers
42228049What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.